Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ)
CNY 10.64
(0.09%)
CNY 10.64
(0.09%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.99 Billion CNY | 3.78% |
| 2022 | 6.73 Billion CNY | 0.22% |
| 2021 | 6.72 Billion CNY | -1.68% |
| 2020 | 6.83 Billion CNY | 17.41% |
| 2019 | 5.82 Billion CNY | 7.0% |
| 2018 | 5.44 Billion CNY | 6.01% |
| 2017 | 5.13 Billion CNY | 41.81% |
| 2016 | 3.62 Billion CNY | 5.29% |
| 2015 | 3.43 Billion CNY | 22.71% |
| 2014 | 2.8 Billion CNY | 1.77% |
| 2013 | 2.75 Billion CNY | 12.72% |
| 2012 | 2.44 Billion CNY | 21.33% |
| 2011 | 2.01 Billion CNY | 10.47% |
| 2010 | 1.82 Billion CNY | -2.97% |
| 2009 | 1.87 Billion CNY | 62.92% |
| 2008 | 1.15 Billion CNY | 10.3% |
| 2007 | 1.04 Billion CNY | 6.19% |
| 2006 | 984.32 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 6.94 Billion CNY | -3.35% |
| 2024 Q1 | 7.18 Billion CNY | 2.77% |
| 2024 Q3 | 6.9 Billion CNY | -0.55% |
| 2023 Q2 | 6.9 Billion CNY | -0.13% |
| 2023 Q3 | 7 Billion CNY | 1.37% |
| 2023 Q4 | 6.99 Billion CNY | -0.15% |
| 2023 FY | 6.99 Billion CNY | 3.78% |
| 2023 Q1 | 6.91 Billion CNY | 2.66% |
| 2022 Q2 | 6.63 Billion CNY | -2.92% |
| 2022 FY | 6.73 Billion CNY | 0.22% |
| 2022 Q4 | 6.73 Billion CNY | 0.31% |
| 2022 Q3 | 6.71 Billion CNY | 1.23% |
| 2022 Q1 | 6.83 Billion CNY | 1.66% |
| 2021 FY | 6.72 Billion CNY | -1.68% |
| 2021 Q2 | 6.88 Billion CNY | -0.02% |
| 2021 Q3 | 6.99 Billion CNY | 1.57% |
| 2021 Q4 | 6.72 Billion CNY | -3.9% |
| 2021 Q1 | 6.88 Billion CNY | 0.74% |
| 2020 FY | 6.83 Billion CNY | 17.41% |
| 2020 Q1 | 5.95 Billion CNY | 2.3% |
| 2020 Q2 | 6.01 Billion CNY | 1.01% |
| 2020 Q3 | 6.32 Billion CNY | 5.15% |
| 2020 Q4 | 6.83 Billion CNY | 8.05% |
| 2019 Q2 | 5.8 Billion CNY | 3.67% |
| 2019 FY | 5.82 Billion CNY | 7.0% |
| 2019 Q4 | 5.82 Billion CNY | -0.28% |
| 2019 Q3 | 5.84 Billion CNY | 0.64% |
| 2019 Q1 | 5.59 Billion CNY | 2.84% |
| 2018 Q4 | 5.44 Billion CNY | -2.92% |
| 2018 Q1 | 5.26 Billion CNY | 2.53% |
| 2018 FY | 5.44 Billion CNY | 6.01% |
| 2018 Q2 | 5.5 Billion CNY | 4.64% |
| 2018 Q3 | 5.6 Billion CNY | 1.78% |
| 2017 FY | 5.13 Billion CNY | 41.81% |
| 2017 Q4 | 5.13 Billion CNY | 27.07% |
| 2017 Q3 | 4.04 Billion CNY | -1.65% |
| 2017 Q2 | 4.1 Billion CNY | 15.06% |
| 2017 Q1 | 3.57 Billion CNY | -1.38% |
| 2016 Q4 | 3.62 Billion CNY | 2.9% |
| 2016 FY | 3.62 Billion CNY | 5.29% |
| 2016 Q3 | 3.51 Billion CNY | 0.45% |
| 2016 Q2 | 3.5 Billion CNY | 3.67% |
| 2016 Q1 | 3.37 Billion CNY | -1.75% |
| 2015 Q4 | 3.43 Billion CNY | 20.34% |
| 2015 Q2 | 2.82 Billion CNY | -0.83% |
| 2015 Q1 | 2.84 Billion CNY | 1.6% |
| 2015 FY | 3.43 Billion CNY | 22.71% |
| 2015 Q3 | 2.85 Billion CNY | 1.2% |
| 2014 Q1 | 2.73 Billion CNY | -0.82% |
| 2014 Q2 | 2.8 Billion CNY | 2.68% |
| 2014 Q4 | 2.8 Billion CNY | -2.18% |
| 2014 Q3 | 2.86 Billion CNY | 2.16% |
| 2014 FY | 2.8 Billion CNY | 1.77% |
| 2013 Q1 | 2.77 Billion CNY | 13.79% |
| 2013 Q2 | 2.68 Billion CNY | -3.44% |
| 2013 Q3 | 2.82 Billion CNY | 5.06% |
| 2013 Q4 | 2.75 Billion CNY | -2.35% |
| 2013 FY | 2.75 Billion CNY | 12.72% |
| 2012 Q3 | 2.4 Billion CNY | -0.4% |
| 2012 Q2 | 2.41 Billion CNY | 14.87% |
| 2012 FY | 2.44 Billion CNY | 21.33% |
| 2012 Q1 | 2.1 Billion CNY | 4.31% |
| 2012 Q4 | 2.44 Billion CNY | 1.67% |
| 2011 Q3 | 2.07 Billion CNY | 2.51% |
| 2011 Q2 | 2.02 Billion CNY | 11.61% |
| 2011 Q1 | 1.81 Billion CNY | -0.4% |
| 2011 Q4 | 2.01 Billion CNY | -3.05% |
| 2011 FY | 2.01 Billion CNY | 10.47% |
| 2010 Q2 | 1.81 Billion CNY | -1.16% |
| 2010 Q1 | 1.83 Billion CNY | -2.19% |
| 2010 Q4 | 1.82 Billion CNY | 0.41% |
| 2010 FY | 1.82 Billion CNY | -2.97% |
| 2010 Q3 | 1.81 Billion CNY | -0.05% |
| 2009 Q3 | 1.24 Billion CNY | 3.41% |
| 2009 Q4 | 1.87 Billion CNY | 50.83% |
| 2009 FY | 1.87 Billion CNY | 62.92% |
| 2009 Q2 | 1.2 Billion CNY | 0.0% |
| 2008 Q4 | 1.15 Billion CNY | 0.0% |
| 2008 FY | 1.15 Billion CNY | 10.3% |
| 2007 FY | 1.04 Billion CNY | 6.19% |
| 2006 FY | 984.32 Million CNY | 0.0% |